Maxillofacial Unit, Queen Alexandra Hospital, Portsmouth, UK.
Department of Histopathology, IDI-IRCCS, Rome, Italy.
J Oral Pathol Med. 2022 Mar;51(3):219-222. doi: 10.1111/jop.13251. Epub 2021 Oct 25.
Superficial parotidectomy has been the gold standard for surgical removal of benign mobile parotid gland tumours. The comparatively newer technique of extracapsular dissection, which involves careful dissection of the tumour itself without the need for formal gland excision, has gained popularity in recent years. Tumours can be removed via smaller incision, and the technique reduces the risk of Frey's syndrome (gustatory sweating) and hollowing at the site of surgery. The risk of facial nerve damage can also be lower with extracapsular dissection. If done carefully, the incidence of tumour recurrence, particularly for pleomorphic adenomas, is comparable with formal parotidectomy. We provide a brief update overview of the current evidence for extracapsular dissection in the treatment of benign parotid tumours and include several meta-analyses which provide evidence for the safety of the technique. We have also included our audited results of over 100 recent extracapsular dissections, with 0% incidence of permanent facial nerve weakness, reported Frey's syndrome and recurrence rates over the last 5 years.
腮腺浅叶切除术一直是外科切除良性可移动腮腺肿瘤的金标准。近年来,一种相对较新的囊外剥离技术越来越受欢迎,该技术涉及到在不需要正式切除腺体的情况下,仔细地分离肿瘤本身。通过更小的切口可以切除肿瘤,并且该技术降低了弗雷氏综合征(味觉出汗)和手术部位凹陷的风险。囊外剥离术也可以降低面神经损伤的风险。如果操作谨慎,肿瘤复发的风险,特别是对于多形性腺瘤,与腮腺切除术相当。我们简要介绍了囊外剥离术在治疗良性腮腺肿瘤方面的最新证据,包括几项荟萃分析,这些分析为该技术的安全性提供了证据。我们还包括了我们对 100 多例最近的囊外剥离术的审核结果,过去 5 年中,面神经永久性无力、报道的弗雷氏综合征和复发率的发生率均为 0%。